These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1085 related items for PubMed ID: 18294116

  • 1. Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment.
    Poon IO.
    Pharmacotherapy; 2008 Mar; 28(3):366-75. PubMed ID: 18294116
    [Abstract] [Full Text] [Related]

  • 2. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S, Bakir SE.
    Drugs; 2000 Mar; 59 Spec No 2():25-37. PubMed ID: 11002856
    [Abstract] [Full Text] [Related]

  • 3. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
    Fournier A, Oprisiu-Fournier R, Serot JM, Godefroy O, Achard JM, Faure S, Mazouz H, Temmar M, Albu A, Bordet R, Hanon O, Gueyffier F, Wang J, Black S, Sato N.
    Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454
    [Abstract] [Full Text] [Related]

  • 4. [Antihypertensive treatment and prevention of dementia].
    Seux ML.
    Ann Cardiol Angeiol (Paris); 1999 Sep; 48(7):512-7. PubMed ID: 12555375
    [Abstract] [Full Text] [Related]

  • 5. Antihypertensive treatments, cognitive decline, and dementia.
    Duron E, Hanon O.
    J Alzheimers Dis; 2010 Sep; 20(3):903-14. PubMed ID: 20182022
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T, Linjer E, Hedner T, Lanke J, De Faire U, Wester PO, Dahlöf B, Scherstén B.
    Blood Press; 2004 Sep; 13(3):137-41. PubMed ID: 15223721
    [Abstract] [Full Text] [Related]

  • 7. [Essential hypertension, dementia, and antihypertensive therapy in geriatric patients].
    Kobalava ZhD, Kotovskaia IuV, Tiul'kina EE.
    Ter Arkh; 2009 Sep; 81(10):64-70. PubMed ID: 19947445
    [Abstract] [Full Text] [Related]

  • 8. Potential for antihypertensive treatment with an AT(1)-receptor blocker to reduce dementia in the elderly.
    Trenkwalder P.
    J Hum Hypertens; 2002 Aug; 16 Suppl 3():S71-5. PubMed ID: 12140732
    [Abstract] [Full Text] [Related]

  • 9. Global impact of stroke.
    Chalmers J.
    Heart Dis; 2000 Aug; 2(2):S13-7. PubMed ID: 11728258
    [Abstract] [Full Text] [Related]

  • 10. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI, Davis BR, Cutler JA, Pressel SL, Whelton PK, Basile J, Margolis KL, Ong ST, Sadler LS, Summerson J, ALLHAT Collaborative Research Group.
    Arch Intern Med; 2006 Nov 13; 166(20):2191-201. PubMed ID: 17101936
    [Abstract] [Full Text] [Related]

  • 11. [Cognitive impairment and dementia in hypertension; the effect of antihypertensive medication].
    Birkenhäger WH, de Leeuw PW, Staessen JA, Wang JG, Forette F, Seux ML.
    Ned Tijdschr Geneeskd; 2000 Jul 29; 144(31):1469-74. PubMed ID: 10941432
    [Abstract] [Full Text] [Related]

  • 12. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH.
    Can J Cardiol; 2004 Aug 29; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [Abstract] [Full Text] [Related]

  • 13. Prevention of dementia: lessons from SYST-EUR and PROGRESS.
    Hanon O, Forette F.
    J Neurol Sci; 2004 Nov 15; 226(1-2):71-4. PubMed ID: 15537524
    [Abstract] [Full Text] [Related]

  • 14. Isolated systolic hypertension: a new challenge in medicine.
    Sulbarán TA, Silva ER, Maestre G.
    J Hum Hypertens; 2002 Mar 15; 16 Suppl 1():S44-7. PubMed ID: 11986893
    [Abstract] [Full Text] [Related]

  • 15. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program.
    Applegate WB, Pressel S, Wittes J, Luhr J, Shekelle RB, Camel GH, Greenlick MR, Hadley E, Moye L, Perry HM.
    Arch Intern Med; 1994 Oct 10; 154(19):2154-60. PubMed ID: 7944835
    [Abstract] [Full Text] [Related]

  • 16. Aggressive blood pressure control and stroke prevention: role of calcium channel blockers.
    Papadopoulos DP, Papademetriou V.
    J Hypertens; 2008 May 10; 26(5):844-52. PubMed ID: 18398322
    [Abstract] [Full Text] [Related]

  • 17. Progress in cardiovascular diseases: cognitive function in essential hypertension.
    Birkenhäger WH, Staessen JA.
    Prog Cardiovasc Dis; 2006 May 10; 49(1):1-10. PubMed ID: 16867845
    [Abstract] [Full Text] [Related]

  • 18. The importance of early antihypertensive efficacy: the role of angiotensin II receptor blocker therapy.
    Basile JN, Chrysant S.
    J Hum Hypertens; 2006 Mar 10; 20(3):169-75. PubMed ID: 16397516
    [Abstract] [Full Text] [Related]

  • 19. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.
    Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S, Bossini A, Fagard R, Gil-Extremera B, Laks T, Kobalava Z, Sarti C, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Birkenhäger WH, Systolic Hypertension in Europe Investigators.
    Arch Intern Med; 2002 Oct 14; 162(18):2046-52. PubMed ID: 12374512
    [Abstract] [Full Text] [Related]

  • 20. Calcium channel blockers in treatment of hypertension.
    Muntwyler J, Follath F.
    Prog Cardiovasc Dis; 2001 Oct 14; 44(3):207-16. PubMed ID: 11727278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.